ANTIBODY AND METHODS FOR SELECTIVE INHIBITION OF T-CELL RESPONSES
The present invention provides compositions, methods, and assays for treating an inflammatory and/or autoimmune disease, and/or transplanted tissue rejection using anti-αβ TCR antibodies and antibody fragments. Anti-αβ TCR antibodies are antibodies which bind to a αβ TCR. Anti-αβ TCR antibod...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng ; spa |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | FRANK J., FOKTA JAMES JOSEPH, HERMANN JOHN JAMES, PUISIS DANIEL RICHARDT, GETTS |
description | The present invention provides compositions, methods, and assays for treating an inflammatory and/or autoimmune disease, and/or transplanted tissue rejection using anti-αβ TCR antibodies and antibody fragments. Anti-αβ TCR antibodies are antibodies which bind to a αβ TCR. Anti-αβ TCR antibodies produced by the hybridomaTOL101 MCB are also provided. Methods for treatment of an inflammatory disease, an autoimmune disease and for tissue transplant rejection using therapeutic dosing regimen of anti-αβ TCR antibodies and antibody fragments and for upregulating the numbers of Treg T-cells are also provided.
Composiciones, métodos y ensayos para tratar una enfermedad inflamatoria y/o enfermedad autoinmune, y/o rechazo de tejido trasplantado usando anticuerpos y fragmentos de anticuerpos anti-aß TCR. Los anticuerpos anti-aß TCR son anticuerpos que se unen a un aß TCR. También se proveen anticuerpos anti-aß TCR producidos por el hibridoma MCB TOL101. También se proveen métodos para el tratamiento de una enfermedad inflamatoria, una enfermedad autoinmune y para el rechazo de trasplante de tejido usando régimen de dosificación terapéutica de anticuerpos y fragmentos de anticuerpos anti-aß TCR y para el aumento de los números de células T Treg. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2014005358A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2014005358A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2014005358A3</originalsourceid><addsrcrecordid>eNrjZHB09AvxdPJ3iVRw9HNR8HUN8fB3CVZw8w9SCHb1cXUO8QxzVfD08_B08gzx9PdT8HdTCNF1dvXxUQhyDQ7w9wt2DeZhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfG-EUYGhiYGBqbGphaOxkQpAgAg1Stb</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTIBODY AND METHODS FOR SELECTIVE INHIBITION OF T-CELL RESPONSES</title><source>esp@cenet</source><creator>FRANK J., FOKTA ; JAMES JOSEPH, HERMANN ; JOHN JAMES, PUISIS ; DANIEL RICHARDT, GETTS</creator><creatorcontrib>FRANK J., FOKTA ; JAMES JOSEPH, HERMANN ; JOHN JAMES, PUISIS ; DANIEL RICHARDT, GETTS</creatorcontrib><description>The present invention provides compositions, methods, and assays for treating an inflammatory and/or autoimmune disease, and/or transplanted tissue rejection using anti-αβ TCR antibodies and antibody fragments. Anti-αβ TCR antibodies are antibodies which bind to a αβ TCR. Anti-αβ TCR antibodies produced by the hybridomaTOL101 MCB are also provided. Methods for treatment of an inflammatory disease, an autoimmune disease and for tissue transplant rejection using therapeutic dosing regimen of anti-αβ TCR antibodies and antibody fragments and for upregulating the numbers of Treg T-cells are also provided.
Composiciones, métodos y ensayos para tratar una enfermedad inflamatoria y/o enfermedad autoinmune, y/o rechazo de tejido trasplantado usando anticuerpos y fragmentos de anticuerpos anti-aß TCR. Los anticuerpos anti-aß TCR son anticuerpos que se unen a un aß TCR. También se proveen anticuerpos anti-aß TCR producidos por el hibridoma MCB TOL101. También se proveen métodos para el tratamiento de una enfermedad inflamatoria, una enfermedad autoinmune y para el rechazo de trasplante de tejido usando régimen de dosificación terapéutica de anticuerpos y fragmentos de anticuerpos anti-aß TCR y para el aumento de los números de células T Treg.</description><language>eng ; spa</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140912&DB=EPODOC&CC=MX&NR=2014005358A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140912&DB=EPODOC&CC=MX&NR=2014005358A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FRANK J., FOKTA</creatorcontrib><creatorcontrib>JAMES JOSEPH, HERMANN</creatorcontrib><creatorcontrib>JOHN JAMES, PUISIS</creatorcontrib><creatorcontrib>DANIEL RICHARDT, GETTS</creatorcontrib><title>ANTIBODY AND METHODS FOR SELECTIVE INHIBITION OF T-CELL RESPONSES</title><description>The present invention provides compositions, methods, and assays for treating an inflammatory and/or autoimmune disease, and/or transplanted tissue rejection using anti-αβ TCR antibodies and antibody fragments. Anti-αβ TCR antibodies are antibodies which bind to a αβ TCR. Anti-αβ TCR antibodies produced by the hybridomaTOL101 MCB are also provided. Methods for treatment of an inflammatory disease, an autoimmune disease and for tissue transplant rejection using therapeutic dosing regimen of anti-αβ TCR antibodies and antibody fragments and for upregulating the numbers of Treg T-cells are also provided.
Composiciones, métodos y ensayos para tratar una enfermedad inflamatoria y/o enfermedad autoinmune, y/o rechazo de tejido trasplantado usando anticuerpos y fragmentos de anticuerpos anti-aß TCR. Los anticuerpos anti-aß TCR son anticuerpos que se unen a un aß TCR. También se proveen anticuerpos anti-aß TCR producidos por el hibridoma MCB TOL101. También se proveen métodos para el tratamiento de una enfermedad inflamatoria, una enfermedad autoinmune y para el rechazo de trasplante de tejido usando régimen de dosificación terapéutica de anticuerpos y fragmentos de anticuerpos anti-aß TCR y para el aumento de los números de células T Treg.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHB09AvxdPJ3iVRw9HNR8HUN8fB3CVZw8w9SCHb1cXUO8QxzVfD08_B08gzx9PdT8HdTCNF1dvXxUQhyDQ7w9wt2DeZhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfG-EUYGhiYGBqbGphaOxkQpAgAg1Stb</recordid><startdate>20140912</startdate><enddate>20140912</enddate><creator>FRANK J., FOKTA</creator><creator>JAMES JOSEPH, HERMANN</creator><creator>JOHN JAMES, PUISIS</creator><creator>DANIEL RICHARDT, GETTS</creator><scope>EVB</scope></search><sort><creationdate>20140912</creationdate><title>ANTIBODY AND METHODS FOR SELECTIVE INHIBITION OF T-CELL RESPONSES</title><author>FRANK J., FOKTA ; JAMES JOSEPH, HERMANN ; JOHN JAMES, PUISIS ; DANIEL RICHARDT, GETTS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2014005358A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2014</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>FRANK J., FOKTA</creatorcontrib><creatorcontrib>JAMES JOSEPH, HERMANN</creatorcontrib><creatorcontrib>JOHN JAMES, PUISIS</creatorcontrib><creatorcontrib>DANIEL RICHARDT, GETTS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FRANK J., FOKTA</au><au>JAMES JOSEPH, HERMANN</au><au>JOHN JAMES, PUISIS</au><au>DANIEL RICHARDT, GETTS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTIBODY AND METHODS FOR SELECTIVE INHIBITION OF T-CELL RESPONSES</title><date>2014-09-12</date><risdate>2014</risdate><abstract>The present invention provides compositions, methods, and assays for treating an inflammatory and/or autoimmune disease, and/or transplanted tissue rejection using anti-αβ TCR antibodies and antibody fragments. Anti-αβ TCR antibodies are antibodies which bind to a αβ TCR. Anti-αβ TCR antibodies produced by the hybridomaTOL101 MCB are also provided. Methods for treatment of an inflammatory disease, an autoimmune disease and for tissue transplant rejection using therapeutic dosing regimen of anti-αβ TCR antibodies and antibody fragments and for upregulating the numbers of Treg T-cells are also provided.
Composiciones, métodos y ensayos para tratar una enfermedad inflamatoria y/o enfermedad autoinmune, y/o rechazo de tejido trasplantado usando anticuerpos y fragmentos de anticuerpos anti-aß TCR. Los anticuerpos anti-aß TCR son anticuerpos que se unen a un aß TCR. También se proveen anticuerpos anti-aß TCR producidos por el hibridoma MCB TOL101. También se proveen métodos para el tratamiento de una enfermedad inflamatoria, una enfermedad autoinmune y para el rechazo de trasplante de tejido usando régimen de dosificación terapéutica de anticuerpos y fragmentos de anticuerpos anti-aß TCR y para el aumento de los números de células T Treg.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; spa |
recordid | cdi_epo_espacenet_MX2014005358A |
source | esp@cenet |
subjects | CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES |
title | ANTIBODY AND METHODS FOR SELECTIVE INHIBITION OF T-CELL RESPONSES |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T22%3A18%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FRANK%20J.,%20FOKTA&rft.date=2014-09-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2014005358A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |